Hyalophane-rich pegmatites are identified from the Manjinggou high-pressure granulite terrain in the Central Zone of North China Craton. Based on field investigation, mineral assemblage and mineral geochemistry, two types of pegmatites can be defined, i.e., hyalophane pegmatite and hyalophane-rich pegmatite. The hyalophane pegmatite is composed of pure hyalophane with 18.7 mol%-19.4 mol% celsian, whereas the hyalophane-rich pegmatite consists of clinopyroxene + titanite + epidote + hyalophane with 11.9 mol%-12.5 mol% celsian. Hyalophane-rich pegmatite has typical magmatic zircons with oscillatory zoning and high Th/U ratios, implying that this type of pegmatite crystallized from special melt similar to magma. SIMS (Cameca 1280) zircon U-Pb dating shows that the crystallization age of the hyalophane-rich pegmatite is 1812±5 Ma, younger than the regional metamorphic age (peak of ca. 1.85 Ga). Zircon 18 O (8.0 ‰-9.3 ‰) and Hf (-7.0 to-2.7) values measured by SIMS suggest that the high-pressure granulite terrain was the source of these veins. Therefore, the hyalophane-rich pegmatite veins were likely to be generated by melting of the high-pressure granulite terrain during post collisional uplift. A quick tectonic uplifting process with a velocity of 0.4 to 0.6 mm/a has been estimated for the high-pressure granulite terrane from the Central Zone of North China Craton. hyalophane, pegmatite, zircon Hf-O isotope, high-pressure granulite, Paleoproterozoic, North China Craton Citation: Qu M, Guo J H, Lai Y, et al. Origin and geological significance of the 1.81 Ga hyalophane-rich pegmatite veins from the high-pressure granulite terrain in the Central Zone
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.